CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin WangCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAMichael D. GreenCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAJae Eun ChoiCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAMiguel A. GijónCayman Chemical Company, Ann Arbor, MI, USAPaul D. KennedyCayman Chemical Company, Ann Arbor, MI, USAJeffrey JohnsonCayman Chemical Company, Ann Arbor, MI, USAPeng LiaoCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAXueting LangCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAIlona KryczekCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAAmanda SellCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAHoujun XiaCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAJiajia ZhouCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAGaopeng LiCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAJing LiCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAWei LiCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAShuang WeiCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USALinda VatanCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAHongjuan ZhangCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAWojciech SzeligaCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USAWei GuInstitute for Cancer Genetics, Department of Pathology and Cell Biology, and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY, USARebecca LiuDepartment of Obstetrics and Gynecology, University of Michigan School of Medicine, Ann Arbor, MI, USATheodore S. LawrenceDepartment of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, MI, USACandice LambDepartment of Chemical Engineering, University of Texas at Austin, Austin, TX, USAYuri TannoDepartment of Chemical Engineering, University of Texas at Austin, Austin, TX, USAMarcin CieślikDepartment of Computational Medicine & Bioinformatics, University of Michigan School of Medicine, Ann Arbor, MI, USAEverett StoneDepartment of Chemical Engineering, University of Texas at Austin, Austin, TX, USAGeorge GeorgiouDepartment of Chemical Engineering, University of Texas at Austin, Austin, TX, USATimothy A. ChanImmunogenomics and Precision Oncology Platform, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USAArul M. ChinnaiyanDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, MI, USAWeiping ZouCenter of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI, USA. [email protected]
2019en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0